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Cardiorespiratory fitness (CRF) is an established risk factor for cardiovascular disease (CVD) outcomes. However, the 
relationship of CRF with risk of ventricular arrhythmias (VAs) is unknown. We aimed to assess the prospective 
association of CRF with the risk of serious VAs. CRF, as measured by maximal oxygen uptake, was assessed using a 
respiratory gas exchange analyser in 2,299 middle-aged men in the Kuopio Ischemic Heart Disease prospective cohort. 
We corrected for within-person variability in CRF levels using data from repeat measurements taken 11 years apart. 
During a median follow-up of 25.3 (interquartile range, 18.7-27.2) years, 73 serious VAs were recorded. The age-adjusted 
regression dilution ratio of CRF was 0.58 (95% confidence interval [CI]: 0.53-0.64). In analysis adjusted for age, the 
hazard ratio (HR) (95% CI) for serious VAs per 1 standard deviation increase in CRF was 0.64 (0.49-0.84). The 
association persisted on additional adjustment for body mass index, systolic blood pressure, history of hypertension, 
prevalent coronary heart disease (CHD), smoking, history of diabetes, cholesterol, alcohol consumption, and physical 
activity 0.64 (0.47 to 0.86). The corresponding adjusted HRs (95% CIs) were 0.29 (0.14-0.59) and 0.29 (0.13-0.62), 
respectively, when comparing the top versus bottom tertiles. The associations were stronger on correction for regression 
dilution bias, remained consistent on exclusion of men with a history of CHD, and did not vary importantly in several 
relevant clinical subgroups. CRF is inversely associated with future risk of serious VAs, independently of several CVD 
risk factors. Further research is needed to assess the causal relevance of these findings. 
 








BMI = body mass index 
BP = blood pressure 
CI = confidence interval 
CRF = cardiorespiratory fitness 
CHD = coronary heart disease 
CVD = cardiovascular disease 
HR = hazard ratio 
PA = physical activity 
RDR = regression dilution ratio 
SD = standard deviation 
SCD = sudden cardiac death 
VA = ventricular arrhythmia 
VF = ventricular fibrillation  












Physical activity (PA) is well established to have important health benefits and these include the prevention of several 
adverse vascular and non-vascular outcomes.1-3 Cardiorespiratory fitness (CRF), as measured by maximal oxygen uptake 
(VO2max) and considered the gold standard for assessing aerobic exercise capacity, is an indicator of cardiopulmonary 
function, and largely reflects  level of PA, as well as genetic components.4-7 CRF is an established and independent risk 
marker for coronary heart disease (CHD), composite cardiovascular disease (CVD) outcomes, as well as all-cause 
mortality.8 Emerging evidence also suggests that higher levels of CRF are protective of atrial fibrillation (AF), which is 
the most common arrhythmia worldwide with clinical significance.9, 10 Serious ventricular arrhythmias (VAs), including 
ventricular tachycardia (VT) and ventricular fibrillation (VF), are life threatening arrhythmias and their common 
manifestation is sudden cardiac death (SCD), typically occurring in the setting of structural heart disease;11 CHD is the 
single most common etiologic factor predisposing patients to VF.  
 
Major CVD risk factors for SCD, such as hypertension, smoking, obesity, and diabetes are also arrhythmogenic 
substrates.12 Given that CHD, SCD and VAs have shared risk factors and with the established relationship between CRF 
and these outcomes (CHD and SCD),13, 14 we hypothesized that CRF would be linked to the risk of VAs. Despite acute 
coronary artery occlusion being the main trigger for VAs,12 the pathogenesis of VAs is still poorly understood. It appears 
that other additional factors may be involved. Potentially, CRF may be an emerging risk factor for VAs; however, to date, 
there has been no previous prospective evaluation of the association of CRF with risk of serious VAs. In this context, we 
aimed to assess the nature and magnitude of the prospective association of CRF with risk of serious VAs (VT and/or VF), 
using a population-based cohort of 1,974 apparently healthy men from eastern Finland. We have previously shown that 
CRF exhibits high within-person variability,15 which could be the result of measurement errors in its estimation, lifestyle 
changes, aging, and chronic disease. Therefore, analysis using only baseline measurements of CRF could underestimate 
the true strength of any association between CRF and outcome (i.e. “regression dilution bias”16). To clarify this issue, 
using repeat measurements of CRF performed several years apart in a random sample of participants, we estimated and 







Our study population is based on the Kuopio Ischemic Heart Disease (KIHD) risk factor study, a general population-based 
prospective cohort study comprising of a representative sample of men aged 42-61 years recruited from the city of Kuopio 
and its surrounding rural communities in eastern Finland. A complete description of the study design, objectives, and 
sampling strategy has been previously described.17 The actual baseline cohort consisted of 2,682 participants who had 
baseline measurements performed between 03/01/1984 and 12/31/1989. In the current analysis, complete information on 
CRF, relevant covariates, and outcomes was available for 2,299 men. The research protocol was approved by the 
institutional review board of the University of Eastern Finland. All study procedures were conducted according to the 
Declaration of Helsinki. Written informed consent was obtained from all participants.  
 
Assessment of CRF and covariates 
Details of the measurements of CRF and risk markers have been described in previous reports.18-22 Briefly, maximal 
oxygen uptake (VO2max) was used as a measure of CRF, which was assessed using a respiratory gas exchange analyser 
during cycle ergometer exercise testing. Repeat measurements of CRF were performed 11 years after baseline in a random 
subset of the study participants.23, 24 The cholesterol content of lipoprotein fractions were measured from fresh samples 
after combined ultracentrifugation and precipitation and were assessed enzymatically (Boehringer Mannheim, Mannheim, 
Germany).23 Self-administered questionnaires were used to assess smoking, alcohol consumption, blood pressure (BP), 
use of medication, and baseline diseases.23 History of CHD was based on a previous myocardial infarction, angina 
pectoris, the use of nitroglycerin for chest pain once a week or more frequently for chest pain. Physical activity (PA) was 







Ascertainment of outcomes 
All serious VAs that occurred from study enrollment to 12/31/2013 were included. Outcomes were collected by linkage to 
the National Hospital Discharge Register. The diagnostic classification of VAs was coded according to ICD-9 codes 
(427.41) or ICD-10 codes (I47.2, I49.0) codes. The definition of non-sustained or sustained VT and/or VF was based on 
electrocardiography, leading to hospital records documentation.26 Documents were cross-checked in detail by two 
physicians. The Independent Events Committee, masked to clinical data, performed classification of outcomes.  
 
Statistical Analyses 
Variables with skewed distributions were natural log transformed to achieve approximately symmetrical distributions. 
Descriptive data were presented as means (standard deviation, SD) or medians (interquartile range, IQR) reported for 
continuous variables and n (percentages) for categorical variables. The partial correlation coefficients were calculated 
using linear regression models adjusted for age, to assess the cross-sectional associations of CRF with various risk 
markers. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using Cox proportional hazard models, 
after confirming no major departure from the assumptions of proportionality of hazards using Schoenfeld residuals.27 CRF 
was modelled as both continuous [per SD increase] and categorical (tertiles) variables. Hazard ratios were calculated with 
adjustment for confounders in three models: (model 1) age; (model 2) model 1 plus systolic blood pressure (systolic BP), 
prevalent CHD, smoking status and history of diabetes mellitus; (model 3) model 1 plus history of hypertension, total 
cholesterol, alcohol consumption, and physical activity. To quantify and correct for within-person variability (regression 
dilution bias) in CRF levels, which is, the extent to which an individual’s CRF measurements vary around the long-term 
average exposure levels (“usual levels”),28 adjusted regression dilution ratios (RDRs) were calculated by regressing 
available repeat measurements of CRF on baseline values.29 This involved dividing the estimated disease association (log 
hazard ratio and its 95% confidence intervals) by the RDR. Finally, we used formal tests of interaction tests to assess 
statistical evidence of effect modification by individual characteristics, such as age, BMI, and other clinically relevant 






The overall mean [standard deviation (SD)] age and CRF of study participants at baseline were 53 (5) years and 30.3 (8.0) 
ml/kg/min, respectively (Table 1). The age-adjusted mean CFRF was 30.2 ml/kg/min. CRF was weakly to moderately 
correlated with several risk markers. There were inverse correlations of CRF with age, alcohol consumption, BMI, BP, 
total cholesterol, and fasting plasma glucose; whereas, positive correlations were observed with PA and HDL-C. Repeat 
measurements of CRF taken at 11 years after baseline were available in a random sample of 576 men. The overall age-
adjusted RDR of CRF was 0.58 (95% CI: 0.53 to 0.64), suggesting that the association of CRF with risk of serious VAs 
using baseline measurements of CRF only, could under-estimate the risk by [(1/0.58)-1]*100 = 72%.  
During a median (interquartile range) follow-up of 25.3 (18.7-27.2) years, 73 incident serious VAs (annual rate 
1.44/1,000 person-years at risk; 95% CI: 1.15 to 1.82) were recorded. Cumulative hazard curves demonstrated a lower 
risk of VAs among males in the top tertile of CRF levels compared to those in the bottom tertile (P<.001 for log-rank test; 
Figure 1). The age-adjusted HR per 1 SD increase in CRF was 0.64 (95% CI: 0.49 to 0.84), which persisted on additional 
adjustment for systolic BP, prevalent CHD, smoking status and history of diabetes was 0.68 (95% CI: 0.51 to 0.91). 
Comparing the extreme tertiles of CRF levels, the corresponding adjusted HRs were 0.29 (95% CI: 0.14 to 0.59) and 0.33 
(95% CI: 0.16 to 0.69), respectively. Correction for regression dilution bias strengthened the respective associations 
(Table 2). The overall results remained consistent in a third model that adjusted for age, history of hypertension, total 
cholesterol, alcohol consumption, and physical activity. Given that CHD is a major risk factor for cardiac arrhythmias, we 
repeated the analysis after excluding participants with a history of CHD. The associations remained qualitatively similar, 
0.59 (95% CI: 0.42 to 0.82) and 0.69 (95% CI: 0.49 to 0.98), respectively per 1 SD increase in CRF, on adjustment for age 
and further for systolic BP, prevalent CHD, smoking status and history of diabetes. The association between CRF and risk 
of VAs was not significantly modified by any clinically relevant characteristic (Figure 2). 
 
Discussion 
We have conducted the first prospective evaluation of the association between CRF and risk of serious VAs in a cohort of 
middle-aged Finnish men aged 42-61 years.  Our descriptive analyses showed mean CRF levels of this population were 
consistent with reference ranges of CRF provided by a representative population of Finnish men and women aged 57-78 
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years.30 Evaluation of the associations showed that CRF, an index of cardiorespiratory functioning and exercise capacity, 
was inversely associated with future risk of serious VAs and independent of several established and emerging CVD risk 
factors. In an analysis that corrected for within-person variability in CRF values, we also observed that using baseline 
measurements of CRF only to assess the association between CRF and serious VAs could underestimate the strength of 
the association under-estimate by about 72%. There was no evidence of effect modification on the association by several 
clinically relevant characteristics. 
We are unable to compare the current findings in the context of previous work, as to our knowledge this is the first 
study to evaluate the prospective association between CRF and serious VAs.  However, several epidemiological studies 
have consistently and robustly shown that CRF is inversely and independently associated with CVD, as well as all-cause 
mortality.5, 6, 8, 20, 31 This association has been demonstrated for CVD specific endpoints, such as acute myocardial 
infarction,22 CHD,20 stroke,32 SCD,13, 31 heart failure,33 as well as AF.10, 33 Our current findings are, therefore, not 
surprising, given that VAs and these CVD outcomes share many common risk factors. Nevertheless, given that this is the 
first prospective study to evaluate this association, other large-scale prospective studies are still needed to confirm the 
current findings. 
Several mechanisms have been postulated to underpin the protective effects of CRF on CVD and all-cause mortality 
outcomes,  and these include both physiological and metabolic processes, such as  (i) beneficial modulation of CVD risk 
factors34, 35; (ii) regulation of cardiac autonomic function and vagal control of heart rate;36 (iii) reduction in 
inflammation;37, 38 and (iv) improvement in endothelial function, BP and lipid levels.39, 40 It is possible that the association 
demonstrated between CRF and  serious VAs may also be exerted via some of these pathways. However, further research 
is needed to elucidate the mechanistic pathways involved in the relationship between CRF, serious VAs and SCD. 
The overall evidence suggests that enhanced CRF through physical activity (particularly aerobic activity) yields 
significant cardiovascular benefits even in individuals at an advanced age. There is established evidence that a physically 
active lifestyle which promotes good CRF levels, has significant health benefits and is associated with reduced risk of 
mortality.8 Both the 2008 and 2018 Physical Activity Guidelines41, 42 recommend 150 to 300 minutes per week of 
moderate-intensity physical activity or 500 to 1,000 MET-minutes of moderate-to-vigorous physical activity, with 
emphasis on low-to-moderate intensity physical activity due to better adherence and safety issues at the population level. 
9 
 
However, majority of the general population do not comply with these recommendations. The 2018 Physical Activity 
Guidelines42 further provide methods of promoting physical activity levels and these include: (i) individual level 
interventions which are based on behavioral change theories; (ii) school-based and community-wide physical activity 
programs; (iii) environmental and policy changes that improve access to physical activity; and (iv) information and 
communication technology. Clinicians should also be encouraged to promote regular physical activity in their patients. 
The established body of epidemiological and clinical evidence demonstrates that CRF is a potentially stronger predictor of 
CVD and mortality than established risk factors such as smoking, hypertension, high cholesterol, and type 2 diabetes 
mellitus. In addition, CRF is a simple, widely available measure that can be measured easily in clinical practice and adds 
additional prognostic value beyond conventional risk factors in predicting CVD and mortality risk.8, 43, 44 CRF should be 
considered a vital sign and measured in clinical practice, as it can provide health professionals with further information to 
improve the management of patients and encourage life-style strategies that can reduce CVD risk.45 Further research is 
needed to evaluate if measurement of CRF can be used to help assess the risk of VAs in both general and specific 
populations, including patients with previous CVD and those with common cardiovascular risk factors or symptoms. 
Several strengths of this study deserve mention, and these include the large-scale population-based prospective cohort 
design comprising of apparently healthy middle-aged men at study entry; long and complete follow-up for all participants; 
access to a comprehensive panel of lifestyle and biological markers, which allowed adequate adjustment for potential 
confounders; and the presence of repeat measurements of CRF, which allowed correction for within-person variability in 
CRF levels. There were a number of limitations, which also deserve consideration. First, the inability to extrapolate the 
findings to women and other ethnicities. Second, the low event rate for serious VAs (N= 73), which precluded assessment 
of effect modification by relevant clinical characteristics on the association. Third, the possibility of residual confounding 
given the observational design. Fourth, the RDR was estimated from only a subset of participants who were randomly 
sampled at 11 years’ follow-up for repeat assessments of CRF, which may constitute a potential bias. Further studies are 
needed with repeat measurements in larger numbers of participants over different intervals in order to assess CRF 
variability in greater detail (e.g., assessment of any changes in mean levels and variability over time). This information 
will enable time-dependent correction for regression dilution. Finally, we included only those serious VT/VF cases which 
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led to hospital register documentation. This meant that very short (non-sustained) VT/VF episodes might have been 





CRF is inversely associated with future risk of serious VAs, independently of several established and emerging 
cardiovascular risk factors. Further research is needed to replicate these findings, assess the causal relevance of the 
association and evaluate whether information on CRF levels can be used to identify individuals at high risk of serious 
VAs in clinical practise. 
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Mean (SD) or median 
(IQR) or n (%) 
 
Pearson correlation 
r (95% CI)a 
CRF (ml/kg/min) 30.26 (8.00) - 
   
Questionnaire/Prevalent conditions   
Age at survey (years) 53 (5) -0.36 (-0.40, -0.32)*** 
Alcohol consumption (g/week) 31.9 (6.4-92.5) -0.09 (-0.14, -0.05)*** 
History of diabetes 81 (3.5) - 
Current smokers 720 (31.3) - 
History of hypertension 686 (29.8) - 
History of CHD 544 (23.7) - 
   
Physical measurements   
BMI (kg/m2) 26.9 (3.5) -0.37 (-0.40, -0.33)*** 
SBP (mmHg) 134 (17) -0.13 (-0.17, -0.09)*** 
DBP (mmHg) 89 (10) -0.14 (-0.18, -0.10)*** 
Physical activity (kj/day) 1210 (631-1988) 0.13 (0.09, 0.17)*** 
   
Lipid markers   
Total cholesterol (mmol/l) 5.91 (1.07) -0.07 (-0.11, -0.03)*** 
HDL-C (mmol/l) 1.29 (0.30) 0.27 (0.23, 0.31)*** 
   
Metabolic and renal markers   
Fasting plasma glucose (mmol/l) 5.33 (1.19) -0.20 (-0.24, -0.16)*** 
Serum creatinine (µmol/1) 89.6 (21.5) -0.02 (-0.07, 0.02) 
Estimated GFR (ml/min/1.73 m2) 87.2 (17.2) -0.04 (-0.09, -0.00) 
 
BMI = body mass index; CHD = coronary heart disease; CRF = cardiorespiratory fitness; DBP = diastolic blood pressure; HDL-C = high-density lipoprotein cholesterol; 
SD = standard deviation; SBP = systolic blood pressure; asterisks indicate the level of statistical significance: *, p<0.05; **, p<0.01; ***, p<0.001; a, Pearson correlation 






Table 2. Association of cardiorespiratory fitness and ventricular arrhythmias 
 
CRF (ml/kg/min) Events/ 
Total 
Model 1  Model 2  Model 3  
  HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value 
Baseline CRF   
Per 1 SD increase in CRF 73 / 2,299 0.64 (0.49 to 0.84) <.001 0.68 (0.51 to 0.91) .009 0.67 (0.51 to 0.88) .004 
T1 (16.06-26.87) 31 / 767 ref  ref  ref  
T2 (26.88-33.26) 31 / 766 0.86 (0.52 to 1.43) .56 0.89 (0.53 to 1.49) .66 0.88 (0.53 to 1.45) .61 
T3 (33.27-65.40) 11 / 766 0.29 (0.14 to 0.59) <.001 0.33 (0.16 to 0.69) .003 0.32 (0.15 to 0.65) .002 
Usual CRFa   
Per 1 SD increase in CRF 73 / 2,299 0.47 (0.30 to 0.73) <.001 0.52 (0.32 to 0.85) .009 0.50 (0.31 to 0.80) .004 
T1 (16.06-26.87) 31 / 767 ref  ref  ref  
T2 (26.88-33.26) 31 / 766 0.77 (0.32 to 1.85) .56 0.82 (0.34 to 1.99) .66 0.80 (0.33 to 1.91) .61 
T3 (33.27-65.40) 11 / 766 0.12 (0.03 to 0.40) <.001 0.15 (0.04 to 0.53) .009 0.14 (0.04 to 0.48) .002 
CI = confidence interval; CRF = cardiorespiratory fitness; HR = hazard ratio; ref = reference; T = tertile; SD = standard deviation;  
a, indicates correction for within-person variability in values of CRF, that is, the extent to which an individual’s CRF measurements vary around a 
long-term average value (“usual CRF values”) 
Model 1: Adjusted for age  
Model 2: Model 1 plus systolic blood pressure, prevalent coronary heart disease, smoking status, and history of diabetes  
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Figure 2. Association of cardiorespiratory fitness with ventricular arrhythmias in clinically relevant subgroups 
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CI = confidence interval; CHD = coronary heart disease; CRF = cardiorespiratory fitness; HR = hazard ratio; SD = 
standard deviation; Vas = ventricular arrhythmias; HRs are adjusted for age, systolic blood pressure, prevalent coronary 
heart disease, smoking status, and history of diabetes; hazard ratios are reported per 1 SD increase in CRF; *, p-value for 
interaction; cut-offs used for age, body mass index, systolic blood pressure, total cholesterol, alcohol consumption, and 
physical activity are based on median values. 
